Illumina MiSeq i100 System
Archived on June 6, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 10:30 AM EDT
- Posted
- May 15, 2026
- Notice type
- Solicitation
- NAICS
- 334516: Analytical Laboratory Instrument Manufacturing
- Agency
- Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION
Notice details
- Office
- FDA OFFICE OF ACQ GRANT SVCS
- Last updated
- Oct 30, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 75F40126Q22123
- Notice ID
- 8af5d39c0b3244db8bdaf54c057a3bf8
Description
This requirement is for the acquisition of one (1) Illumina MiSeq i100 Whole Genome Sequencing System for the FDA Irvine Medical Products Laboratory (IRVLMP). The procurement is being conducted on a sole-source basis under RFO FAR Part 12 and FAR 13.106-1(b)(1), as the Illumina MiSeq i100 System is the only system determined capable of meeting the Government’s minimum requirements for compatibility with existing validated laboratory workflows, consumables, sequencing methods, software environments, and operational procedures. The requirement includes associated components, software, delivery, installation, training, and manufacturer warranty support.
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
Lifecycle
- 3Version 3SolicitationArchivedCurrent
Illumina MiSeq i100 System
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75F40126Q22123
Archive Date
Jun 6, 2026
Office Address
Rockville, MD, 20852